Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Glioblastoma × Chemoradiotherapy × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 11 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Nasopharyngeal Carcinoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Neoplasms 2 Adenocarcinoma 2 Pathologic Complete Response 1 Overall Survival Comparison Between the 2 Arms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Margins of Excision 1 Lymphatic Metastasis 1 Locally Advanced Malignant Neoplasm 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 Head and Neck Neoplasms 1 HPV-Related Squamous Cell Carcinoma 1 Glioblastoma 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Adenosquamous 1 Breast Neoplasms 1 Anus Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Temozolomide 39 Radiotherapy 18 Lomustine 12 Bevacizumab 11 Carmustine 8 Radiation 7 Procarbazine 4 Magnetic Resonance Spectroscopy 4 Surgical Procedures, Operative 3 pembrolizumab 2 depatuxizumab mafodotin 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Drug Therapy 2 Dihematoporphyrin Ether 2 DNA Methylation 2 Carboplatin 2 ABT-414 2 trans-sodium crocetinate 1 tofacitinib 1 sargramostim 1 rindopepimut 1 niraparib 1 marizomib 1 enzastaurin 1 edotecarin 1 contrast agent BR1 1 cediranib 1 carmustine, poliferprosan 20 drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685605 2025-10-14

INTRAGO-II

Universitätsmedizin Mannheim

Phase 3 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡